David Liang., a PRISMS senior, has been recognized as a "Top 300 Scholar" in the prestigious 2024 Regeneron Science Talent Search (STS). This competition, sponsored by the Society for Science and Regeneron Pharmaceuticals Inc., drew 2,162 senior participants this year, the largest pool since the 1960s.
David's project, "Discovery and Validation of Small Molecule TIGIT Inhibitors for Cancer Immunotherapy," submitted to the STS, earned him a $2,000 award. Additionally, his success brought another $2,000 to the school for STEM-related activities.
We extend our heartfelt congratulations to David for his significant achievement and eagerly await the announcement of the top 40 finalists on January 24, 2024. More information: https://www.societyforscience.org/regeneron-sts/2024-scholars/